Skip to main content
Clinical Trials/NCT02884063
NCT02884063
Completed
Not Applicable

Utilizing Free DNA in Embryo Culture Media for Preimplantation Genetic Screening

Al Baraka Fertility Hospital0 sites100 target enrollmentMay 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chromosome Abnormalities
Sponsor
Al Baraka Fertility Hospital
Enrollment
100
Primary Endpoint
DNA isolation
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

In the way for developing and optimizing protocol to be used as non- invasive methodology used as routine testing for PGS.

This protocol is to be adapted to replace the using of life embryo cells for genetic testing and aneuploidy study as well as for any type of genetic testing including single gene disorder or HLA typing or study.

Detailed Description

Compare 100 embryos studied using NGS for chromosomal aneuploidies, and compare the results came from free media DNA with this results.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
December 1, 2019
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Al Baraka Fertility Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ahmad Mustafa Mohamed Metwalley

IVF laboratory manager

Al Baraka Fertility Hospital

Eligibility Criteria

Inclusion Criteria

  • all abnormal/aneuploidy embryos rejected for embryo transfer.

Exclusion Criteria

  • all embryos had unsuccessful diagnosis with blastomere biopsy.

Outcomes

Primary Outcomes

DNA isolation

Time Frame: 2 years

reading amplified DNA using NGS

Secondary Outcomes

  • NGS evaluation(2 years)
  • Comparison with cell reading using NGS(2 years)

Similar Trials